Nervous System Markers Market

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Nervous System Markers Market aims to provide a comprehensive presentation of the global market for Nervous System Markers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nervous System Markers. Nervous System Markers Market contains market size and forecasts of Nervous System Markers in global, including the following market information:
Global Nervous System Markers Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Nervous System Markers Market Sales, 2018-2023, 2024-2035, (K Units)
Global top five Nervous System Markers companies in 2022 (%)
The global Nervous System Markers market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Imaging Biomarkers Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Nervous System Markers include Athena Diagnostics, Myriad RBM, AbaStar MDx, QIAGEN and Thermo Fisher Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nervous System Markers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nervous System Markers Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, by Type, 2022 (%)
Imaging Biomarkers
Metabolomics Biomarkers
Proteomic Biomarkers
Genomics Biomarkers
Global Nervous System Markers Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, by Application, 2022 (%)
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Depression
Schizophrenia
Huntington's Disease
Parkinson's Disease
Alzheimer's Disease
Global Nervous System Markers Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Nervous System Markers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nervous System Markers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nervous System Markers revenues share in global market, 2022 (%)
Key companies Nervous System Markers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nervous System Markers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athena Diagnostics
Myriad RBM
AbaStar MDx
QIAGEN
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nervous System Markers, market overview.
Chapter 2: Global Nervous System Markers market size in revenue and volume.
Chapter 3: Detailed analysis of Nervous System Markers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nervous System Markers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nervous System Markers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.